Skip to Content

Investor Relations

As of August 7, 2019, Option Care and BioScrip have merged to become one national team, solely dedicated to infusion care. Option Care Health, Inc. is the largest independent...
Read More

Corporate Profile

As of August 7, 2019, Option Care and BioScrip have merged to become one national team, solely dedicated to infusion care. Option Care Health, Inc. is the largest independent home and alternate site infusion services provider in the United States. With over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and employees.

Investor Overview

News Releases

Date Title and Summary
Toggle Summary Option Care Health to Participate in the William Blair Virtual Growth Stock Conference
BANNOCKBURN, Ill. , May 28, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the William Blair Virtual Growth Stock Conference on Thursday, June
Toggle Summary Option Care Health Selected as Preferred Pharmacy Partner To Prepare and Distribute Breakthrough Cancer Therapy
First surgery-free treatment option for rare, difficult-to-treat urinary tract cancer requires complex clinical protocol BANNOCKBURN, Ill. , May 21, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc.  (“ Option Care Health” or the “Company”) (NASDAQ: OPCH), the nation’s largest independent provider
Toggle Summary Option Care Health Announces Financial Results for the First Quarter and Provides an Update on the Impact of COVID-19 Pandemic
BANNOCKBURN, Ill. , May 07, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2020